Acurx Pharmaceuticals (ACXP) vs Addex Therapeutics (ADXN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Acurx Pharmaceuticals is the larger company by market cap ($6.3 million vs $6.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACXP | ADXN |
|---|---|---|
| Share price | $1.04 | $3.47 |
| Market cap | $6.30M | $6.08M |
| 1-day change | +0.97% | +2.06% |
| EPS (TTM) | $-1.90 | $-7.56 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-7.97M | — |
| 52-week high | $7.54 | $10.43 |
| 52-week low | $0.90 | $2.56 |
| Distance from 52-week high | -86.21% | -66.73% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +1534.62% | — |
| Average volume | 97.29K | 383.35K |
| Shares outstanding | 6.06M | 1.75M |
| Employees | 4 | 3 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Acurx Pharmaceuticals
ACXP stock →Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections.
Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees
About Addex Therapeutics
ADXN stock →Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes.
Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees
ACXP vs ADXN FAQ
Which is bigger, Acurx Pharmaceuticals or Addex Therapeutics?
Acurx Pharmaceuticals (ACXP) is larger, with a market capitalization of $6.30M compared with $6.08M for Addex Therapeutics (ADXN).
Are Acurx Pharmaceuticals and Addex Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.